Since metformin has been reported to partially reverse the insulin-resistance in diabetes mellitus type 2, we also investigated the effect of the insulin-sensitizing drug rosiglitazone on oxidative stress-induced apoptosis. This evidence concerns the gene INS and Insulin resistance.